1Faubion WA,Loftus EV,Harm sen WS,et al.The natural history of corticosteroid therapy for inflammatory bowel disease:a popu- lation - based study[J].Gastroenterology, 2001,121(2) :255 - 260.
2Rutgeerts P, Van Assche G, Vermeire S. Optimizing anti TNF treatment in inflamm atory bowel disease[J].Gastroenterology, 2004,126(6) :1593 - 1610.
3Targan SR, Hanauer SB, Van Deventer SJ.A Short -term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor Al- pha for Crohn's Disease cA2 Study Group[J].N Engl J Med, 1997,337:1029.
4Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance in- fliximab for Crohn's Disease: the ACCENT I Randomised Trial [J].Lancet, 2002,359 (9317) : 1541.
5De Ridder L, Rings EH, Damen GM, et al. Infliximab Dependency in Pediatric Crohns Disease: longterm Follow- up of an Unse- lected Cohos[J].Intlamm Bowel Dis, 2008,14(3 ) : 353 - 358.
